8 medical device companies that beat the COVID-19 pandemic and prospered

Companies that lost sales

While diagnostics and imaging companies seemingly benefited the most from the COVID-19 pandemic, other elective procedure device companies took hits in their sales.

Teleflex
-2.2% less sales.
5.1% growth in R&D spending.
-2.8% less employees.

Intuitive Surgical
-2.7% less sales.
6.8% growth in R&D spending.
10.3% growth in employees.

Stryker
-3.6% less sales.
1.3% growth in R&D spending.
7.5% growth in employees.

Abbott (medical device segment)
-3.7% less sales.
8.3% growth in R&D spending.

Boston Scientific
-7.7% less sales.
-2.6% less R&D spending.
5.6% growth in employees.

Owens & Minor
-7.9% less sales.

GE Healthcare
-9.7% less sales.

Alcon
-9.9% less sales.
2.6% growth in R&D spending.
18.3% growth in employees.

Smith+Nephew
-11.2% less sales.
5.1% growth in R&D spending.
2.9% growth in employees.

Johnson & Johnson (medical device segment)
-11.6% less sales.
7.2% growth in R&D.

Zimmer Biomet
-12% less sales.
-17.2% less R&D spending.
0.5% growth in employees.

Dentsply Sirona
-17.1% less sales.
-12.4% less R&D spending.
-1.3% less employees.